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Synthesis of wt NOXA-B
Fmoc-protected amino acids were purchased from Novabiochem (Merck), or Sigma-Aldrich. The peptide was prepared using a microwave-assisted automated peptide synthesiser (Liberty Blue; CEM) on Rink amide MBHA resin (0.057 mmol) using standard Oxyma/DIC chemistry with systematically repeated steps of coupling and deprotection (20% piperidine in DMF) interspaced with washing (note: The Arg6 residue was double-coupled). Once assembly was complete, the resin-attached peptide was N-terminally acetylated (acetic anhydride (10 eq.), DIPEA (10 eq.) in DMF for 2 h) before being washed and dried. The peptide was then cleaved from the resin with simultaneous removal of side-chain protection by treatment with a cocktail of trifluoroacetic acid/H2O/triisopropylsilane (95:2.5:2.5 v/v, 3 × 2 mL) for 2 h at room temperature. Resin was removed by filtration, and the peptide precipitated by the addition of ice-cold Et2O (25 mL) and centrifuged. Supernatant was removed, and the peptide pellet dried under a stream of nitrogen, before being dissolved in H2O and freeze-dried.
Crude wt NOXA-B was purified by HPLC in two stages. Firstly, using a linear gradient at 12 mL/min of 5-50% acetonitrile in water (each containing 0.1% TFA) across a RediSep 
Analytical Ultracentrifugation
Analytical ultracentrifugation (AUC) was performed at 20 °C in a Beckman Proteomelab XL-A or Beckman Proteomelab XL-I analytical ultracentrifuge using an An-60 Ti rotor and 2-channel centrepieces. Sedimentation equilibrium experiments were made up in PBS (137 mM NaCl, 2.7 mM KCl, 8.2 mM Na2HPO4 and 1.8 mM KH2PO4) at 50 µM peptide concentration for homomeric assemblies and 50 µM peptide concentration of both peptides for heteromeric assemblies and to 120 µL. The reference channel was loaded with 130 µL of PBS solution. Equilibrium distributions were measured twice per speed, in 4 krpm increments, and with rotor speeds from 40 to 60 krpm. Data were fitted to single ideal species models using Ultrascan II (http:/www.ultrascan.uthscsa.edu). A better fit for CC-Di_E2 data was found using monomer-dimer equilibrium with a fixed monomer mass. 95% confidence limits were obtained by Monte Carlo analysis of the fits. The partial specific volume ( ̅ ) for each of the peptides and the buffer density were calculated using Ultrascan II.
Fluorescence Anisotropy -Direct Binding

MCL-1/FITC-BID Direct Titration
Titration of MCL-1 into FITC-BID was performed in a 96-well plate in Tris Buffer (50 mM Tris, 150 mM NaCl, pH 7.4) + 0.01% Triton-X-100 with the concentration of MCL-1 starting at 3.75 µM, diluted over 12 points in a 1/2 regime with [FITC-BID] fixed at 25 nM. Plates were read after 1 hour and 21 hours incubation. Assays were performed in triplicate (both test wells and blank control wells).
BCL-xL /FITC-BID Direct Titration
Titration of BCL-xL into FITC-BID was performed in a 384-well plate in Tris Buffer + 0.01% Triton-X-100 + 0.02 mg/mL BSA with the concentration of BCL-xL starting from 5 µM, diluted over 16 points in a 1/2 regime with [FITC-BID] fixed at 25 nM. Plates were read after 1 hour and 21 hours incubation. Assays were performed in triplicate (both test wells and blank wells).
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Flu-p53/hDM2
Direct titration performed as described previously. 1 
Fluorescence Anisotropy -Competition Assays
MCL-1/FITC-BID Competition Assays
MCL-1/FITC-BID competition assays were performed in Tris Buffer (50 mM, Tris, 150 mM NaCl, pH 7.4) + 0.01% Triton-X-100 with [MCL-1] fixed at 150 nM. Assays were performed in triplicate (both test wells and blank wells). Plates were read after 1-2 hours and 20-21 hours incubation, data shown is from 20-21 hours incubation.
BCL-xL /FITC-BID Competition Assays
BCL-xL /FITC-BID competition assays were performed in Tris Buffer (50 mM, Tris, 150 mM NaCl, pH 7.4) + 0.01% Triton-X-100 + 0.02 mg/mL BSA with [BCL-xL] fixed at 100 nM. For each plate, a BAK sequence used previously by us, was titrated against BCL-xL /FITC-BID as a positive control. For the positive control, both test and blank wells were run as single titrations, for all other competition assays, test wells were run in triplicate. Plates were read after 1-2 hours and 20-21 hours incubation, data shown is from 20-21 hours incubation.
Flu-p53/hDM2 Competition Assays
Flu-p53/hDM2 competition assays were performed in Tris Buffer (50 mM, Tris, 150 mM NaCl, pH 7.4) + 0.01% Triton-X-100 with [hDM2] fixed at 150 nM. For each plate, Nutlin-3a was titrated against Flup53/hDM2 as a positive control. For the positive control, both test and blank wells were run as single titrations, for all other competition assays, test wells were run in triplicate. Plates were read after 1-2 hours incubation and 20-21 hours incubation, data shown is from 1-2 hours incubation. 
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Peptide Sequence
FITC-BID (FITC)-Ahx-EDIIRNIARHLAQVGDS[Nle]DRSIW-NH
Flu-p53
Ac-SQETFSDLWKKPENNVC Flu -NH wt NOXA-B 
Ac-AAQLRRIGDKVNLRQKLLN-NH
BAK
Ac-Ahx-GQVGRQLAIIGDDINR-NH
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Figure S6a
Analytical Ultracentrifugation fits (top) and residuals (bottom) for peptide CC-Di_S. Rotor speeds were 40,000 rpm (blue); 48,000 rpm (red); 52,000 rpm (green); 60,000 rpm (purple). The fits are shown for a single ideal species of mass 6010 Da.
Figure S6b
Analytical Ultracentrifugation fits (top) and residuals (bottom) for peptide CC-Di_E1. Rotor speeds were 44,000 rpm (blue); 48,000 rpm (red); 52,000 rpm (green); 60,000 rpm (purple). The fits are shown for a single ideal species of mass 6912 Da.
Figure S6c
Analytical Ultracentrifugation fits (top) and residuals (bottom) for peptide CC-Di_E2. Rotor speeds were 44,000 rpm (blue); 48,000 rpm (red); 52,000 rpm (green); 60,000 rpm (purple). Data was fitted to a monomer-dimer equilibrium with a fixed monomer mass, returning a Kd of 7.26 µM.
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Figure S6d
Analytical Ultracentrifugation fits (top) and residuals (bottom) for peptide CC-Di-A_S plus CC-Di-B. Rotor speeds were 40,000 rpm (blue); 48,000 rpm (red); 52,000 rpm (green); 60,000 rpm (purple). The fits are shown for a single ideal species of mass 6273 Da.
Figure S6e
Analytical Ultracentrifugation fits (top) and residuals (bottom) for peptide CC-Di-A plus CCDi-B_S. Rotor speeds were 44,000 rpm (blue); 48,000 rpm (red); 52,000 rpm (green); 60,000 rpm (purple). The fits are shown for a single ideal species of mass 6678 Da. 
Figure S8a
Direct titration of MCL-1 into FITC-BID to give an Kd = 92 ± 5 nM (21 h), which is consistent with that described previously (50 ± 20 nM).
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Figure S8b
Representative fluorescence-anisotropy competition assay for the inhibition of MCL-1/FITC-BID interaction by a control wt NOXA-B peptide. IC50 = 375 ± 22 nM Figure S8c Direct titration of BCL-xL into FITC-BID, data fit to a logistic model to give an EC50 of 41 ± 6 nM (21 h), which is consistent with that described previously (21 ± 7 nM). 
